Evidence map›Paper›PMID 25092121›Full record

ArticleAmerican journal of preventive medicine2014

Harm reduction at the crossroads: the case of e-cigarettes.

Wasim Maziak

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Racial/Ethnic Differences in Associations of Non-cigarette Tobacco Product Use With Subsequent Initiation of Cigarettes in US Youths.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. The Gateway Effect of E-cigarettes: Reflections on Main Criticisms.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Article
  8. Article
  9. Article
  10. For Smoking Cessation, E-Cigarette Flavors Aren't Required.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Article
  11. Review
  12. Article
  13. Perceptions of E-Cigarettes among Black Youth in California.International journal of environmental research and public health · 2017
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Smoking Norms and the Regulation of E-Cigarettes.American journal of public health · 2015
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Wasim MaziakDepartment of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida; and Syrian Center for Tobacco Studies, Aleppo, Syria. Electronic address: wmaziak@fiu.edu.

Funding

Advancing addiction research and capacity to guide tobacco control in the EasternR01DA035160 · NIDA · FLORIDA INTERNATIONAL UNIVERSITY · PI MAZIAK, WASIM · 2012 to 2017
$1.5M
NIDA NIH HHS R01 DA035160
6 · The paper itself

Abstract

The recent popularity of electronic (e)-cigarettes and their rapid uptake by youth has ignited the debate about their role as a harm-reduction strategy. Harm reduction in the context of tobacco control contends that in societies that have achieved considerable success in curbing smoking, leaving the remaining hard-to-quit smokers with an abstinence-only option is unfair, especially when less-harmful choices are available. On one side of the debate are those who call for caution in endorsing such products until critical pieces of evidence about their safety and potential become available, whereas the other side argues that waiting until all questions about e-cigarettes are answered is dogma driven. In this piece, I try to discuss the unresolvable contention between harm-reduction goals of offering safer options to smokers, and those of e-cigarette makers of being commercially viable and profitable.

Indexed as

Harm ReductionSmoking PreventionAdolescentCommerceElectronic Nicotine Delivery SystemsHumansSmoking Cessation

Identifiers

PMID25092121
PMCPMC4171135

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.